Skip To Main Content
Tumour Immunology on Muck Rack

Tumour Immunology

As seen in: MSN UK, Nature, Wiley Online Library, Yahoo Canada, PLOS ONE, Frontiers, Biomed Central (BMC), The Lancet, The Journal of Biological Chemistry, Inkl and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tumour

Contact Tumour, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Lupus may be triggered by a common virus – new research

|
By Graham Taylor, Tumour Immunology
| MSN UK Verified
; ; ; Continue reading More for You ; ; Continue reading More for You
Open in Who Shared View Duplicates (699) Issue with article?

Lupus may be triggered by a common virus - new research

|
By Graham Taylor, Tumour Immunology
| Inkl
Epstein-Barr virus is a type of herpesvirus. Kateryna Kon/ Shutterstock Around 5 million people worldwide live with the autoimmune condition lupus. This condition can cause a range of symptoms, including tiredness, fever, joint pain and a characteristic butterfly-shaped rash across the cheeks and nose. For some people, these symptoms are mild and only flare-up occassionally.
Open in Who Shared View Duplicates (7) Issue with article?

Frontiers | The Berlin-Hannover ICANS severity assessment–a novel bedside test to evaluate CAR T-cell-associated neurotoxicity

|
By Thiemo Malte, Franz Felix, Tumour Immunology, Eric Anil
| Frontiers
ORIGINAL RESEARCH article Volume 17 - 2026 | https://doi.org/10.3389/fneur.2026.1726779 This article is part of the Research TopicNovel Insights into CAR T-cell Associated Neurotoxicity - Volume IIView all 3 articles 1 Introduction Therapy with chimeric antigen receptor (CAR) T-cells has marked a significant milestone in the treatment of refractory or relapsed hematological malignancies, including diffuse large B-cell lymphoma (DLBCL), multiple myeloma (MM), and acute lymphoblastic B-cell...
Open in Who Shared Issue with article?
See all 11 articles